down arrow

Hind.Bio Science

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE597C01021
  • NSEID:
  • BSEID: 532041
INR
9.45
0.61 (6.9%)
BSENSE

Apr 11, 12:51 PM

BSE+NSE Vol: 2.15 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Hindustan Bio Sciences Ltd stock-summary
stock-summary
Hindustan Bio Sciences Ltd
Micro Cap
Pharmaceuticals & Drugs
Hindustan Bio Science Ltd (Formerly known Hindustan Softel Ltd) was incorporated as Public Limited Company on December 16, 1991. The Company engaged in the manufacturing and sale of pharmaceutical products is an integrated firm with diversified operations in pharmaceutical and biotechnology sectors. The Company initially commenced operations in 1992 by sourcing bulk drugs (APIs) and drug intermediates for the Industry with a wellspring of global suppliers and associates.
Company Coordinates stock-summary
Company Details
H No 8-2-269/S PlotNo 31 RdNo2, Sagar Co-Op Hous Banjara Hills Hyderabad Telangana : 500034
stock-summary
Tel: 91-40-23555161/23555181
stock-summary
pharma.hindustanbio@gmail.com
Registrar Details
Venture Capital & Corporate Investments Ltd , 12-10-167,, MIG- 167,, Bharat Nagar Colony, Hyderabad
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR None Cr
Number of Shares
None Cr
Face Value
INR None
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Venkata Rama Mohan Raju Jampana (9.39%)

Highest Public shareholder

Satyasai Kolli (2.59%)

Individual Investors Holdings

84.04%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
J.V.R. Mohan Raju
Chairman & Managing Director
6.0 lacs
B R Rao
Independent Director
12.5 k
J Uma
Director
12.5 k
K Rama Chandra Raju
Independent Director
12.5 k
M Satyanarayana Raju
Independent Director
12.5 k
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Purchases
2.92126
0%
 
100
Purchases
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Traded Goods
1.03
100.00%
 
100
Traded Goods
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 9 Cr (Micro Cap)

stock-summary
P/E

9.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

2.15

stock-summary
Return on Equity

26.00%

stock-summary
Price to Book

9.06